You have 9 free searches left this month | for more free features.

Pilocarpine HCl 1.25%

Showing 1 - 25 of 1,490

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Presbyopia Trial in United States (AGN-190584, Vehicle)

Completed
  • Presbyopia
  • Bakersfield, California
  • +22 more
Feb 14, 2022

Near Vision Trial in Tehran (Pilocarpine 1.25% Eye drop)

Recruiting
  • Near Vision
  • Pilocarpine 1.25% Eye drop
  • Tehran, Iran, Islamic Republic of
    Hamideh Sabbaghi
Oct 1, 2022

Post Operative Pain Trial in Karachi (Bupivacaine Hcl 0.25% Inj, Bupivacaine Hcl 0.25% Inj plus Dexmedetomidine 1micro/kg)

Completed
  • Post Operative Pain
  • Bupivacaine Hcl 0.25% Inj
  • Bupivacaine Hcl 0.25% Inj plus Dexmedetomidine 1micro/kg
  • Karachi, Sindh, Pakistan
    Sindh Institute of Urology and Transplantation. Department of An
Jun 25, 2023

Type 2 Diabetes Trial in Daejeon (CT-L01, Alogliptin Benzoate 25 mg, Metformin HCl XR 1,000 mg)

Completed
  • Healthy
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Jan 10, 2023

Lumbar Disc Herniation Trial (Dexmedetomidine Hydrochloride 'Precedex' combined with, Lumbar epidural analgesia with Bupivacaine

Not yet recruiting
  • Lumbar Disc Herniation
  • Dexmedetomidine Hydrochloride 'Precedex' combined with
  • +3 more
  • (no location specified)
Apr 29, 2023

Presbyopia Trial in United States (Vehicle, Pilocarpine HCl Ophthalmic Solution)

Completed
  • Presbyopia
  • Vehicle
  • Pilocarpine HCl Ophthalmic Solution
  • Chandler, Arizona
  • +35 more
Nov 27, 2021

Presbyopia Trial in United States (Pilocarpine HCl Ophthalmic Solution, Vehicle)

Completed
  • Presbyopia
  • Pilocarpine HCl Ophthalmic Solution
  • Vehicle
  • Dothan, Alabama
  • +34 more
Nov 27, 2021

Chronic Postoperative Pain Trial in Montréal (Bupivacaine Hydrochloride 0.25% Injection Solution_#2, EPINEPHrine 1:200,000 /

Recruiting
  • Chronic Postoperative Pain
  • Bupivacaine Hydrochloride 0.25% Injection Solution_#2
  • +3 more
  • Montréal, Quebec, Canada
    St. Mary's Hospital Center
Oct 24, 2022

Presbyopia Trial in United States (CSF-1, Vehicle)

Completed
  • Presbyopia
  • Sun City, Arizona
  • +16 more
Jan 8, 2023

Presbyopia Trial in United States (CSF-1, Vehicle)

Completed
  • Presbyopia
  • Chandler, Arizona
  • +17 more
Jan 8, 2023

Postoperative Pain Trial in Czechia, United States (Bupivacaine HCl, SKY0402)

Completed
  • Postoperative Pain
  • Birmingham, Alabama
  • +8 more
Jun 7, 2022

Breast Cancer Trial in Worldwide (Liposomal doxorubicin HCl, Cyclophosphamide, Trastuzumab)

Completed
  • Breast Cancer
  • Liposomal doxorubicin hydrochloride
  • +4 more
  • Kufstein, Austria
  • +21 more
Jun 21, 2022

Postoperative Pain Trial in United States (Bupivacaine HCl, SKY0402)

Completed
  • Postoperative Pain
  • Arcadia, California
  • +6 more
Feb 11, 2021

Postoperative Pain Trial in Georgia, United States (SKY0402, Bupivacaine HCl)

Completed
  • Postoperative Pain
  • San Clemente, California
  • +6 more
Feb 11, 2021

Advanced Solid Tumor Trial (ZG0895 Hydrochloride for Injection)

Not yet recruiting
  • Advanced Solid Tumor
  • ZG0895 Hydrochloride for Injection
  • (no location specified)
May 25, 2023

Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

Active, not recruiting
  • Hairy Cell Leukemia
  • Moxetumomab Pasudotox-tdfk
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Analgesia Trial in Bellaire, San Antonio (HTX-011, Bupivacaine Hydrochloride, Ibuprofen)

Completed
  • Analgesia
  • Bellaire, Texas
  • +1 more
Oct 25, 2023

Postoperative Pain, Total Shoulder Arthroplasty, Multimodal Analgesia Trial in United States (HTX-011, Bupivacaine

Completed
  • Postoperative Pain
  • +2 more
  • Little Rock, Arkansas
  • +4 more
Oct 25, 2023

COPD Trial (Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination)

Not yet recruiting
  • COPD
  • Ipratropium / Levosalbutamol Fixed Dose Combination
  • Ipratropium + Levosalbutamol Free Dose Combination
  • (no location specified)
Jun 5, 2023

Interstitial Cystitis, Bladder Pain Syndrome Trial in United States (VNX001, Placebo, Lidocaine)

Not yet recruiting
  • Interstitial Cystitis
  • Bladder Pain Syndrome
  • Escondido, California
  • +7 more
Feb 26, 2023

Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

Recruiting
  • Hairy Cell Leukemia
  • Hairy Cell Leukemia Variant
  • CD22CART cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Hypertension Trial in China (Fixed [Per/Ind/Aml], Free [Per/Ind + Aml])

Completed
  • Hypertension
  • Fixed [Per/Ind/Aml]
  • Free [Per/Ind + Aml]
  • Beijing, Beijing, China
  • +41 more
Apr 18, 2023

Type 1 Diabetes Trial in Washington (Control IQ)

Recruiting
  • Type 1 Diabetes
  • Control IQ
  • Washington, District of Columbia
    Children's National
Sep 1, 2022

Metastatic Pancreatic Cancer Trial in Burlington (Anamorelin Hydrochloride, Placebo)

Recruiting
  • Metastatic Pancreatic Cancer
  • Anamorelin Hydrochloride
  • Placebo
  • Burlington, Massachusetts
    Lahey Hospital & Medical Center
Feb 1, 2022

Shoulder Pain Trial in Dallas (Single-injection bupivacaine HCl plus liposomal bupivacaine, Single-injection bupivacaine HCl

Enrolling by invitation
  • Shoulder Pain
  • Single-injection bupivacaine HCl plus liposomal bupivacaine
  • Single-injection bupivacaine HCl plus a subsequent bupivacaine CISB
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 1, 2022